<DOC>
	<DOCNO>NCT01481142</DOCNO>
	<brief_summary>The objective study observe document efficacy safety 5 Adacolumn treatment , administer weekly 5 week , specific subset ulcerative colitis patient . The patient subset interest moderate/severe , steroid-dependent , active ulcerative colitis insufficient response intolerance immunosuppressant and/or biological agent .</brief_summary>
	<brief_title>Adacolumn Refractory UC Patients Trial</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients enrol study 18 75 year old moderate severe , steroiddependent , active ulcerative colitis document clinical symptom , endoscopic finding histology . Patients ulcerative colitis clinical activity ( CAI ) ≥6 endoscopic activity index ( EAI ) ≥4 . Patients insufficient response intolerance immunosuppressant and/or biological treatment agent . Patients required adequate peripheral venous access allow completion apheresis treatment . A patient exclude study he/she meet follow criterion : 1 . Is febrile ( body temperature &gt; 38ºC ) . 2 . Has evidence toxic megacolon . 3 . Has know obstructive disease gastrointestinal system . 4 . Is anticipate need surgery within next 24 week . 5 . Has history hypersensitivity reaction associate apheresis procedure intolerance apheresis procedure . 6 . Has proctocolectomy , total colectomy , ileostomy , stoma ileal pouchanal anastomosis . 7 . Has history allergic reaction heparin heparininduced thrombocytopenia . 8 . Has know infection enteric pathogen , pathogenic ovum parasite , positive test cytomegalovirus . 9 . Has symptomatic hypotension . 10 . Has history physical finding consistent cerebrovascular accident . 11 . Has history myocardial infarction unstable angina within previous 6 month . 12 . Has undergone coronary artery bypass graft surgery angioplasty within previous 6 month . 13 . Has congestive heart failure ( New York Heart Association Class III IV ) . 14 . Has prosthetic heart valve , pacemaker permanent implant . 15 . Has severe cardiovascular peripheral vascular disease . 16 . Has liver disease define level aspartate aminotransferase ( AST/SGOT ) , alanine aminotransferase ( ALT/SGPT ) alkaline phosphatase great 2.5 × upper limit normal range laboratory perform test . 17 . Has history cirrhosis . 18 . Has know bleed disorder ( prothrombin time [ PT ] partial thromboplastin time [ PTT ] great 1.5 × upper limit normal range laboratory perform test ) require concomitant anticoagulant therapy purpose apheresis treatment . 19 . Has prior history suggestive hypercoagulable disorder , include 1 episode pulmonary embolism deep vein thrombosis . 20 . Has know infection hepatitis B C human immunodeficiency virus . 21 . Has abnormal haematology parameter define severe anaemia haemoglobin &lt; 8.5 g/dL , white blood cell count &lt; 3500/µL granulocyte count &lt; 2000/µL . 22 . Has fibrinogen level &gt; 700 mg/dL . 23 . Has renal insufficiency , define serum creatinine level great 150 % upper limit normal range laboratory perform test . 24 . Has major surgery within previous 6 week . 25 . Has follow type infection : An active infection within 4 week successful completion antibiotic treatment bacterial infection . Febrile viral infection within 4 week prior entry study . Systemic fungal infection require therapy complete within 12 week prior entry study . 26 . Current drug alcohol abuse . 27 . Is pregnant , lactate plan become pregnant study . 28 . Has use investigational medicinal product , biologic agent device within last 30 day . 29 . Adults lack capacity unable give consent due physical mental incapacity . 30 . Prisoners patient undergone psychiatric treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>